Details of the Drug Reposition

General Information of This Drug (ID: DMQ9QM6)

Drug Name
STP-206   DMQ9QM6
Synonyms Live-bacteria-based biologic (necrotizing enterocolitis), Sigma-Tau Pharmaceuticals/Danisco

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Necrotizing enterocolitis of newborn DISUGBKH KB88 Phase 2 [1]
------------------------------------------------------------------------------------
1 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Enterocolitis DISYACTL 1A40.Z Phase 1/2 [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 ClinicalTrials.gov (NCT01954017) STP206 for the Prevention of NEC. U.S. National Institutes of Health.